Abiopharma

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Armstrong World Industries Schedules First-Quarter 2026 Earnings Release and Conference Call

Rubico Inc. Announces Reverse Stock Split

VULCAN ANNOUNCES FIRST QUARTER 2026 CONFERENCE CALL

Smithfield® and Pabst Blue Ribbon Kick Off Grilling Season with a Bold New Beer Brat

AV’s UES Awarded $25M AFRL Contract to Mature Human Performance Technologies for Warfighter Readiness

Asset Acquisitions and Disposals: Acquisition of Shares by Wholly-Owned Subsidiary - Update Announcement

Director Li Tiezheng 🟡 adjusted position in 225.3K shares (2 derivative) of FinVolution Group (FINV) at $1.01 Transaction Date: Apr 03, 2026 | Filing ID: 015432

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0000950103-26-005413 <b>Size:</b> 330 KB

Wang Yuxiang 🟡 adjusted position in 1.1M shares (2 derivative) of FinVolution Group (FINV) at $1.01 Transaction Date: Apr 03, 2026 | Filing ID: 015430

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001918704-26-009540 <b>Size:</b> 935 KB

Chen Pingping 🟡 adjusted position in 705.4K shares (2 derivative) of FinVolution Group (FINV) at $1.01 Transaction Date: Apr 03, 2026 | Filing ID: 015428

New Form 3 - Rectitude Holdings Ltd. <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001213900-26-040785 <b>Size:</b> 3 KB

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements